CLINICAL TRIALS PROFILE FOR AMPICILLIN AND SULBACTAM
✉ Email this page to a colleague
All Clinical Trials for Ampicillin And Sulbactam
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00044746 ↗ | Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 | 2000-10-01 | Phase IV Open-Label Foot Infection Study is being conducted to generate comparative Efficacy and Safety data in Diabetic Inpatients. |
| NCT00137007 ↗ | Zithromax EV in Community-Acquired Pneumonia (CAP) | Completed | Pfizer | Phase 4 | 2003-11-01 | The intravenous (IV) regimen containing azithromycin (Zithromax) plus ampicillin-sulbactam is consistent with current guidelines for the treatment of CAP. In fact the International guidelines for the treatment of CAP in hospitalised patients suggests the use of a combination between a b-lactam and a macrolide. This trial will allow investigators to evaluate the efficacy of azithromycin plus ampicillin-sulbactam in the treatment of hospitalized subjects with community acquired pneumonia. In addition, this trial will allow investigators to evaluate the safety and toleration of combination therapy. |
| NCT00356148 ↗ | The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients. | Completed | Marmara University | Phase 4 | 2003-10-01 | This is a single center trial to compare the rate of surgical site infection (SSI) in normal (BMI equal to or less than 25; Control Group)) and overweight (BMI over 25) women who are undergoing breast cancer surgery. The overweight patients are further randomized into two groups; in one group patients receive prophylactic antibiotics (ampicillin/sulbactam; Prophylaxis Group), in the other they do not (No Prophylaxis Group). |
| NCT00368537 ↗ | Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 | 2006-09-01 | The purpose of this study is to compare the safety and efficacy of the antibiotic tigecycline with other antibiotics, ampicillin-sulbactam, and amoxicillin-clavulanate in the treatment of a complicated skin and/or skin structure infection (cSSSI). |
| NCT00630513 ↗ | T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam | Completed | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 4 | 2008-01-01 | The aim of the study was to compare the activity (efficacy and safety) of Ertapenem administered according to a short treatment for three days versus a short treatment for three days with AS in patients with an community acquired IAI of mild to moderate severity. |
| NCT00630513 ↗ | T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam | Completed | St. Orsola Hospital | Phase 4 | 2008-01-01 | The aim of the study was to compare the activity (efficacy and safety) of Ertapenem administered according to a short treatment for three days versus a short treatment for three days with AS in patients with an community acquired IAI of mild to moderate severity. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ampicillin And Sulbactam
Condition Name
| Condition Name for Ampicillin And Sulbactam | |
| Intervention | Trials |
| Intra-Abdominal Infection | 2 |
| Carbapenem Resistant Bacterial Infection | 1 |
| Pneumonia, Aspiration | 1 |
| Cholecystitis; Acute, With Cholelithiasis | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for Ampicillin And Sulbactam
Trials by Country
Clinical Trial Progress for Ampicillin And Sulbactam
Clinical Trial Phase
Clinical Trial Sponsors for Ampicillin And Sulbactam
Sponsor Name
